Common Stock, Shares Authorized of Checkpoint Therapeutics, Inc. from 31 Dec 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Checkpoint Therapeutics, Inc. quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2015 to 31 Mar 2025.
  • Checkpoint Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending 31 Mar 2025 was 175,000,000, a 119% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Checkpoint Therapeutics, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 175,000,000 +95,000,000 +119% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 175,000,000 +95,000,000 +119% 31 Dec 2024 10-Q 13 May 2025 2025 Q1
Q3 2024 175,000,000 +95,000,000 +119% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 175,000,000 +95,000,000 +119% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 80,000,000 +30,000,000 +60% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 80,000,000 +30,000,000 +60% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 80,000,000 -55,000,000 -41% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 80,000,000 -55,000,000 -41% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 50,000,000 -85,000,000 -63% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 50,000,000 +36,500,000 +270% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 135,000,000 0 0% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 135,000,000 0 0% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 135,000,000 +40,000,000 +42% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 13,500,000 -81,500,000 -86% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 135,000,000 +40,000,000 +42% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 135,000,000 +40,000,000 +42% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 95,000,000 +35,000,000 +58% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 95,000,000 0 0% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 95,000,000 +35,000,000 +58% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 95,000,000 +35,000,000 +58% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 60,000,000 0 0% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 95,000,000 +35,000,000 +58% 31 Dec 2019 10-Q 06 Aug 2020 2020 Q2
Q3 2019 60,000,000 0 0% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 60,000,000 0 0% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 60,000,000 +10,000,000 +20% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 60,000,000 0 0% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q3 2018 60,000,000 +10,000,000 +20% 30 Sep 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 60,000,000 +10,000,000 +20% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 50,000,000 0 0% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 60,000,000 +10,000,000 +20% 31 Dec 2017 10-Q 02 Nov 2018 2018 Q3
Q3 2017 50,000,000 0 0% 30 Sep 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 50,000,000 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 50,000,000 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 50,000,000 0 0% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 50,000,000 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q4 2015 50,000,000 31 Dec 2015 10-K 21 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.